Sacubitril Valsartan Sodium Extended-Relesae Tablets(Taizhou Overseas Pharma)

沙库巴曲缬沙坦钠缓释片（越洋医药）

Report date: 2025/09/23 09:58:07

Base Information

Drug NameSacubitril Valsartan Sodium Extended-Relesae Tablets(Taizhou Overseas Pharma)
Drug Alias NameSacubitril and Valsartan Sodium Hydrate缬沙坦/沙库巴曲sacubitril + valsartan trisodium hemipentahydrate沙库巴曲缬沙坦钠Valsartan/sacubitril +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeprilysin inhibitorsAngiotensin II Receptor Type 1 antagonists
TargetsAngiotensin II Receptor Type 1Neprilysin
Therapy Area/IndicationsHeart Failure
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesTaizhou Overseas Pharmaceuticals Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTaizhou Overseas Pharmaceuticals Co Ltd
Inactive CompaniesN/A
Active IndicationsHeart Failure
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A